Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models
PhD ceremony: Mr. A.R.M. van der Bilt, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models
Promotor(s): prof. E.G.E. de Vries, prof. A.G.J. van der Zee, prof. S. de Jong
Faculty: Medical Sciences
Standard therapy for ovarian cancer, consisting of platinum-based chemotherapy and surgical debulking, has been unchanged since its introduction over a decade ago. Other chemotherapeutic regimens did not improve the poor prognosis of advanced ovarian cancer patients. Alternative therapeutic strategies are therefore being pursued, by applying molecular targeted drugs. These drugs interfere with key biological processes relevant to ovarian cancer biology, amongst which are the potential of these cancers to evade programmed cell death (apoptosis) and to create a vascular supply (angiogenesis). In this thesis the effects of proapoptotic and anti-angiogenic targeted drugs was investigated in preclinical ovarian cancer models.
Last modified: | 13 March 2020 01.01 a.m. |
More news
-
06 June 2025
India-Netherlands Hydrogen Valley Fellowship Programme announced
To coincide with World Environment Day, 5 June 2025, the Indian Department of Science and Technology and the University of Groningen yesterday announced a Hydrogen Valley Fellowship Programme Partnership, allowing talented Indian scholars working on...
-
28 May 2025
Gaan avondmensen cognitief sneller achteruit dan ochtendmensen?
Wie ’s avonds opleeft en laat naar bed gaat, heeft een grotere kans op cognitieve achteruitgang dan een ochtendmens, blijkt uit UMCG-onderzoek.
-
27 May 2025
An adventure in the brain
In the exhibition Brainstorm in the University Mueseum, Iris Sommer and two other brain researchers from Groningen explain the gut-brain connection, how it was discovered that the brain does what it does, and how games motivate you to perform...